Registro completo de metadatos
Campo DC Valor Lengua/Idioma
dc.provenanceCONICET-
dc.creatorSookoian, Silvia Cristina-
dc.creatorPirola, Carlos José-
dc.date2018-06-22T20:40:28Z-
dc.date2018-06-22T20:40:28Z-
dc.date2017-04-13-
dc.date2018-06-04T17:01:40Z-
dc.date.accessioned2019-04-29T15:39:26Z-
dc.date.available2019-04-29T15:39:26Z-
dc.date.issued2017-04-13-
dc.identifierSookoian, Silvia Cristina; Pirola, Carlos José; Nonalcoholic fatty liver disease: Biomarkers support decisions around pharmacological intervention; John Wiley & Sons Inc; Hepatology (Baltimore, Md.); 65; 4; 13-4-2017; 1417-1419-
dc.identifier0270-9139-
dc.identifierhttp://hdl.handle.net/11336/49789-
dc.identifierCONICET Digital-
dc.identifierCONICET-
dc.identifier.urihttp://rodna.bn.gov.ar:8080/jspui/handle/bnmm/298733-
dc.descriptionWe read with great interest the article of Ajmera et al. (1) reporting on the relationship between bio- markers and the histological disease spectrum of nonal- coholic fatty liver disease (NAFLD) in a large population of well-characterized patients from the Non- alcoholic Steatohepatitis Clinical Research Network. The researchers found a significant association between circulating levels of total plasminogen activator inhibitor 1 (tPAI1) and the presence of nonalcoholic steatohepa- titis, which was independent of clinical confounding factors. (1) The clinical value of this result should be highlighted, also having important implications for tai- loring pharmacological interventions.-
dc.descriptionFil: Sookoian, Silvia Cristina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Médicas. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Médicas; Argentina-
dc.descriptionFil: Pirola, Carlos José. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Médicas. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Médicas; Argentina-
dc.formatapplication/pdf-
dc.formatapplication/pdf-
dc.languageeng-
dc.publisherJohn Wiley & Sons Inc-
dc.relationinfo:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1002/hep.28866-
dc.relationinfo:eu-repo/semantics/altIdentifier/url/https://aasldpubs.onlinelibrary.wiley.com/doi/abs/10.1002/hep.28866-
dc.rightsinfo:eu-repo/semantics/restrictedAccess-
dc.rightshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/-
dc.sourcereponame:CONICET Digital (CONICET)-
dc.sourceinstname:Consejo Nacional de Investigaciones Científicas y Técnicas-
dc.sourceinstacron:CONICET-
dc.source.urihttp://hdl.handle.net/11336/49789-
dc.subjectNAFLD-
dc.subjectNASH-
dc.subjectBIOMARKERS-
dc.subjectMETABOLIC SYNDROME-
dc.subjectMedicina Critica y de Emergencia-
dc.subjectMedicina Clínica-
dc.subjectCIENCIAS MÉDICAS Y DE LA SALUD-
dc.titleNonalcoholic fatty liver disease: Biomarkers support decisions around pharmacological intervention-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.typeinfo:ar-repo/semantics/articulo-
Aparece en las colecciones: CONICET

Ficheros en este ítem:
No hay ficheros asociados a este ítem.